|
US5458879A
(en)
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
|
US5554380A
(en)
|
1994-08-04 |
1996-09-10 |
Kv Pharmaceutical Company |
Bioadhesive pharmaceutical delivery system
|
|
US6319513B1
(en)
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
|
US20010016577A1
(en)
|
1998-08-24 |
2001-08-23 |
Douglas Joseph Dobrozsi |
Oral mucoadhesive compositions containing gastrointestinal actives
|
|
WO2001028515A1
(en)
*
|
1999-10-22 |
2001-04-26 |
Líf-Hlaup ehf. Bio-Gels Pharmaceuticals Inc. |
Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
|
|
PT1997478E
(pt)
|
2001-02-15 |
2013-12-10 |
Access Pharma Inc |
Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
|
|
US7544348B2
(en)
|
2001-02-15 |
2009-06-09 |
Access Pharmaceuticals, Inc. |
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
|
|
EP1531837A4
(en)
*
|
2001-06-07 |
2006-11-15 |
Chiou Consulting Inc |
COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF APHTEOUS ULCERS AND LESIONS DUE TO HERPES
|
|
US20030059446A1
(en)
*
|
2001-09-18 |
2003-03-27 |
Kulkarni Arun B. |
Physically stable sprayable gel composition
|
|
US20060018937A1
(en)
*
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
|
JP2007522077A
(ja)
*
|
2003-08-21 |
2007-08-09 |
アクセス ファーマシューティカルズ， インコーポレイテッド |
粘膜の疾患および障害の予防および処置のための液体製剤
|
|
US8030003B2
(en)
|
2004-12-07 |
2011-10-04 |
Children's Hospital Medical Center |
Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
|
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US8679545B2
(en)
|
2005-11-12 |
2014-03-25 |
The Regents Of The University Of California |
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
CL2007002214A1
(es)
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
|
US20090149433A1
(en)
|
2007-11-13 |
2009-06-11 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
US20100216754A1
(en)
*
|
2007-11-13 |
2010-08-26 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
CN101969956B
(zh)
*
|
2007-11-13 |
2014-03-05 |
梅里蒂奇制药公司 |
皮质类固醇组合物
|
|
US8865692B2
(en)
|
2007-11-13 |
2014-10-21 |
Meritage Pharma, Inc |
Compositions for the treatment of gastrointestinal inflammation
|
|
US20090264392A1
(en)
|
2008-04-21 |
2009-10-22 |
Meritage Pharma, Inc. |
Treating eosinophilic esophagitis
|
|
CA2723215A1
(en)
|
2008-05-01 |
2009-11-05 |
Revalesio Corporation |
Compositions and methods for treating digestive disorders
|
|
US8030297B2
(en)
*
|
2008-05-14 |
2011-10-04 |
Otonomy, Inc. |
Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
|
|
ES2358158T3
(es)
|
2008-07-21 |
2011-05-06 |
Dr. Falk Pharma Gmbh |
Formulación farmacéutica para el tratamiento del tracto digestivo superior.
|
|
HUE051538T2
(hu)
|
2008-08-20 |
2021-03-01 |
Univ California |
Kortikoszteroidok a gyomor-bél traktus gyulladásos betegségeinek kezelésére
|
|
AU2009322556A1
(en)
|
2008-12-01 |
2011-07-21 |
Children's Hospital Medical Center |
Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
|
|
MX2011013061A
(es)
*
|
2009-06-05 |
2012-02-28 |
Aciex Therapeutics Inc |
Formulaciones oftalmicas de fluticasona y metodos de uso.
|
|
WO2010144865A2
(en)
|
2009-06-12 |
2010-12-16 |
Meritage Pharma, Inc. |
Methods for treating gastrointestinal disorders
|
|
JP5833007B2
(ja)
|
2009-08-31 |
2015-12-16 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
ステロイドを含む局所製剤
|
|
MX364947B
(es)
|
2009-10-01 |
2019-05-15 |
Adare Pharmaceuticals Inc |
Composiciones de corticosteroides administradas oralmente.
|
|
EP3970726A1
(en)
*
|
2010-06-24 |
2022-03-23 |
ViroPharma Biologics LLC |
Methods of treatment for esophageal inflammation
|
|
CN103974706A
(zh)
|
2011-10-06 |
2014-08-06 |
N·V·努特里奇亚 |
嗜酸细胞性食管炎的治疗
|
|
WO2014074995A1
(en)
*
|
2012-11-09 |
2014-05-15 |
Scidose, Llc |
Enema composition for treatment of ulcerative colitis having long term stability
|
|
EP2938327B1
(en)
|
2012-12-26 |
2017-12-06 |
Otic Pharma Ltd. |
Foamable otic pharmaceutical compositions
|
|
WO2014155397A1
(en)
|
2013-03-29 |
2014-10-02 |
Italchimici S.P.A. |
Oral suspension for treating eosinophilic esophagitis
|
|
WO2015034678A2
(en)
|
2013-09-06 |
2015-03-12 |
Aptalis Pharmatech, Inc. |
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
|
|
PT2886108T
(pt)
|
2013-12-23 |
2019-04-01 |
Dr Falk Pharma Gmbh |
Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago
|
|
US20160184431A1
(en)
|
2014-03-11 |
2016-06-30 |
Promius Pharma Llc |
Topical compositions comprising a corticosteroid
|
|
CA2946373C
(en)
*
|
2014-05-01 |
2018-07-31 |
Integral Biosystems Llc |
Membrane-adherent self-assembled systems for treatment of ocular disorders
|
|
US11623008B2
(en)
|
2014-08-20 |
2023-04-11 |
Professional Compounding Centers Of America |
Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
|
|
DE102014119576A1
(de)
*
|
2014-12-23 |
2016-06-23 |
Ernst-Moritz-Arndt-Universität Greifswald |
Pharmazeutische Arzneimittelform zur Applikation auf Schleimhäuten
|
|
US20180140619A1
(en)
*
|
2015-05-04 |
2018-05-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for delivering therapeutic agents into the colon
|
|
BR102018008324A2
(pt)
|
2018-04-25 |
2019-11-05 |
Laboratorios Ferring Ltda |
composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico
|